Recent News

• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.02.2025 - FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
• 09.02.2025 - FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
• 09.02.2025 - FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
• 08.27.2025 - FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.27.2025 - FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.27.2025 - FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
• 08.18.2025 - FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation
• 08.18.2025 - FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

Recent Filings

• 08.18.2025 - 8-K Current report
• 08.18.2025 - EX-99.1 EX-99.1
• 08.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - 8-K Current report